Medicine & Health

Brad Warner, MD, a beloved pediatric surgeon and researcher at Washington University School of Medicine who specialized in gastrointestinal surgery in children, died at his home Friday, April 4, 2025. He was 66.

Matthew Bersi, a biomedical engineer at Washington University, has been named a 2025 Young Innovator in Cellular and Molecular Bioengineering by the Biomedical Engineering Society.

WashU Medicine surgeons led a long-term study that showed patients who received a hip resurfacing procedure maintained a higher level of athletic activity years after their surgery than those who received a total hip replacement.

Researchers at the McKelvey School of Engineering will investigate the effect of estrogen on thoracic aortic aneurysm development and develop patient-specific biomarkers to manage the disease.

Megan Tierney Baldridge, MD, PhD, an associate professor in the Department of Medicine at WashU Medicine, received a $100,000 grant to explore the interactions between the viruses that infect bacteria, known as bacteriophages, and human intestinal epithelial cells.

Researchers at Washington University have received a $4 million grant to study specialized cells that could help treat kidney disease.

Researchers at WashU Medicine found that a small population of immune cells in the mouse intestine prevents allergic responses to food, suggesting that targeting such cells therapeutically could potentially lead to a new treatment for allergies.

Researchers at WashU Medicine have harnessed the internal circadian clock of the body to deliver medication for an inflammatory illness precisely when it was most needed.

Aaron Y. Lee, MD, a leader in applying artificial intelligence to ophthalmology research and patient care, will head the John. F. Hardesty, MD, Department of Ophthalmology & Visual Sciences at WashU Medicine.

A clinical trial led by Richard S. Hotchkiss, MD, a professor of anesthesiology at WashU Medicine, has found that treating critically ill COVID-19 patients with an immune-boosting protein reduces life-threatening secondary infections, a major cause of death in such patients.